相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Elina Khatoon et al.
SEMINARS IN CANCER BIOLOGY (2022)
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Maleki Parisa Dana et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential
Giovanni Luca Beretta et al.
CELLS (2022)
Latifolin, a Natural Flavonoid, Isolated from the Heartwood of Dalbergia odorifera Induces Bioactivities through Apoptosis, Autophagy, and Necroptosis in Human Oral Squamous Cell Carcinoma
Hyung-Mun Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das et al.
DRUG RESISTANCE UPDATES (2021)
Stable W/O/W multiple nanoemulsion encapsulating natural tocotrienols and caffeic acid with cisplatin synergistically treated cancer cell lines (A549 and HEP G2) and reduced toxicity on normal cell line (HEK 293)
Revathi Raviadaran et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
Sascha D. Markowitsch et al.
CANCERS (2021)
The role of epithelial-mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
Jihye Seo et al.
ARCHIVES OF PHARMACAL RESEARCH (2021)
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib et al.
BIOMEDICINES (2021)
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis
Fabrizio Fontana et al.
CELL PROLIFERATION (2021)
Curcumin Targets Both Apoptosis and Necroptosis in Acidity-Tolerant Prostate Carcinoma Cells
Yoon-Jin Lee et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Epidemiology and Prevention of Prostate Cancer
Giorgio Gandaglia et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells
Sang-Han Lee et al.
NUTRITION RESEARCH AND PRACTICE (2021)
gamma-Tocotrienol and alpha-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells
Spencer Asay et al.
MOLECULES (2020)
Caspase-8: The double-edged sword
Ranadip Mandal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells
Christine Moore et al.
BMC CANCER (2020)
Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
Milad Ashrafizadeh et al.
LIFE SCIENCES (2020)
Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets
Marina Montagnani Marelli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway
Yanlan Li et al.
ANTI-CANCER DRUGS (2019)
Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
Chao-Yue Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
δ-Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells
Fabrizio Fontana et al.
CELL PROLIFERATION (2019)
Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements
Vaishali Aggarwal et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway
Kai Dun Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
Goniothalamin Induces Necroptosis and Anoikis in Human Invasive Breast Cancer MDA-MB-231 Cells
Patompong Khaw-on et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Celastrol Induces Necroptosis and Ameliorates Inflammation via Targeting Biglycan in Human Gastric Carcinoma
Dandan Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A gene regulatory network to control EMT programs in development and disease
Hassan Fazilaty et al.
NATURE COMMUNICATIONS (2019)
Tocotrienols Modulate a Life or Death Decision in Cancers
Shiau-Ying Tham et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents
Fabrizio Fontana et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
Li Liu et al.
BIOLOGICAL RESEARCH (2019)
Semi-preparative HPLC purification of δ-tocotrienol (δ-T3) from Elaeis guineensis Jacq. and Bixa orellana L. and evaluation of its in vitro anticancer activity in human A375 melanoma cells
Giangiacomo Beretta et al.
NATURAL PRODUCT RESEARCH (2018)
Profiling Prostate Cancer Therapeutic Resistance
Cameron A. Wade et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs
Asaf A. Qureshi et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Tocotrienols: The promising analogues of vitamin E for cancer therapeutics
Bethsebie Lalduhsaki Sailo et al.
PHARMACOLOGICAL RESEARCH (2018)
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Brandon Bumbaca et al.
ACTA PHARMACEUTICA SINICA B (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Riccardo Cristofani et al.
CELL DEATH & DISEASE (2018)
Molecular Basis of Drug Resistance and Insights for New Treatment Approaches in mCRPC
Silvana Giacinti et al.
ANTICANCER RESEARCH (2018)
Combination Effect of δ-Tocotrienol and γ-Tocopherol on Prostate Cancer Cell Growth
Chiaki Sato et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2017)
Cancer's Achilles' Heel: Apoptosis and Necroptosis to the Rescue
Atreyi Dasgupta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer
Karuna Mittal et al.
BRITISH JOURNAL OF CANCER (2017)
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression
Kazumasa Komura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Annatto Tocotrienol Induces a Cytotoxic Effect on Human Prostate Cancer PC3 Cells via the Simultaneous Inhibition of Src and Stat3
Ryosuke Sugahara et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2015)
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
Sven Perner et al.
ONCOTARGET (2015)
Polyphenon E, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis
Federica Rizzi et al.
CARCINOGENESIS (2014)
Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer
John M. Fitzpatrick et al.
EUROPEAN UROLOGY (2014)
The multiple facets of drug resistance: one history, different approaches
Evandro Luis Niero et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
Zeze Fu et al.
BMC CANCER (2013)
γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products
Kouichi Kani et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
X. Sui et al.
CELL DEATH & DISEASE (2013)
Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population
Sze Ue Luk et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
RIPK-Dependent Necrosis and Its Regulation by Caspases: A Mystery in Five Acts
Douglas R. Green et al.
MOLECULAR CELL (2011)
A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line
Takahito Hara et al.
CELL BIOLOGY INTERNATIONAL (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
